These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 23834205)
1. Acid-citrate-dextrose Formula A versus heparin as primary catheter lock solutions for therapeutic apheresis. Osby M; Barton P; Lam CN; Tran MH Transfusion; 2014 Mar; 54(3):735-43. PubMed ID: 23834205 [TBL] [Abstract][Full Text] [Related]
2. Citrate versus heparin for apheresis catheter locks: an efficacy analysis. Passero BA; Zappone P; Lee HE; Novak C; Maceira EL; Naber M J Clin Apher; 2015 Feb; 30(1):22-7. PubMed ID: 25132635 [TBL] [Abstract][Full Text] [Related]
3. Catheter outcomes in the short-term inpatient setting: a controlled quality improvement study comparing citrate and heparin lock. Parikh S; Nijmeh R; Van Cleef S; Timmerman S; Bhatt UY; Agarwal AK Semin Dial; 2012 May; 25(3):351-6. PubMed ID: 22074231 [TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576 [TBL] [Abstract][Full Text] [Related]
5. Regional citrate anticoagulation with calcium replacement in pediatric apheresis. Sigler K; Lee J; Srivaths P J Clin Apher; 2018 Jun; 33(3):274-277. PubMed ID: 29027706 [TBL] [Abstract][Full Text] [Related]
6. Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: an effective protocol. Nedelcu E; Ziman A; Fernando LP; Cook K; Bumerts P; Schiller G J Clin Apher; 2008; 23(2):66-73. PubMed ID: 18286495 [TBL] [Abstract][Full Text] [Related]
7. Quantification of systemic delivery of substrates for intermediate metabolism during citrate anticoagulation of continuous renal replacement therapy. Balik M; Zakharchenko M; Otahal M; Hruby J; Polak F; Rusinova K; Stach Z; Vavrova J; Jabor A Blood Purif; 2012; 33(1-3):80-7. PubMed ID: 22212643 [TBL] [Abstract][Full Text] [Related]
8. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731 [TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714 [TBL] [Abstract][Full Text] [Related]